About Cogentix Medical
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: CGNT
- Previous Close: $2.19
- 50 Day Moving Average: $1.98
- 200 Day Moving Average: $1.86
- 52-Week Range: $0.71 - $2.99
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 108.50
- P/E Growth: -1.04
- Market Cap: $130.96M
- Outstanding Shares: 60,349,000
- Beta: 0.78
- Net Margins: -8.83%
- Return on Equity: -17.44%
- Return on Assets: -5.18%
Companies Related to Cogentix Medical:
- Debt-to-Equity Ratio: 1.75%
- Current Ratio: 1.90%
- Quick Ratio: 1.29%
What is Cogentix Medical's stock symbol?
Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."
Where is Cogentix Medical's stock going? Where will Cogentix Medical's stock price be in 2017?
1 brokers have issued 1 year target prices for Cogentix Medical's stock. Their predictions range from $1.15 to $1.15. On average, they anticipate Cogentix Medical's share price to reach $1.15 in the next twelve months.
When will Cogentix Medical announce their earnings?
Cogentix Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.
Who owns Cogentix Medical stock?
Cogentix Medical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Broadfin Capital LLC (1.25%), Renaissance Technologies LLC (0.91%), Bard Associates Inc. (0.27%) and Teton Advisors Inc. (0.19%). Company insiders that own Cogentix Medical stock include Kenneth A Samet, Kevin H Roche and Lewis C Pell.
Who sold Cogentix Medical stock? Who is selling Cogentix Medical stock?
Cogentix Medical's stock was sold by a variety of institutional investors in the last quarter, including Bard Associates Inc..
Who bought Cogentix Medical stock? Who is buying Cogentix Medical stock?
Cogentix Medical's stock was acquired by a variety of institutional investors in the last quarter, including Broadfin Capital LLC and Renaissance Technologies LLC. Company insiders that have bought Cogentix Medical stock in the last two years include Kenneth A Samet, Kevin H Roche and Lewis C Pell.
How do I buy Cogentix Medical stock?
Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Cogentix Medical stock cost?
One share of Cogentix Medical stock can currently be purchased for approximately $2.17.